Trial Outcomes & Findings for Evaluation of Addition of Dexamethasone to Transversus Abdominis Plane (TAP) Peripheral Nerve Block (NCT NCT01303003)
NCT ID: NCT01303003
Last Updated: 2018-09-21
Results Overview
Documenting the time required by patients to the first request of additional analgesia.
COMPLETED
NA
24 participants
24 hours post-op
2018-09-21
Participant Flow
No data are available for this study, due to the fact that the PI has left the institution. Multiple efforts were made, by Research and senior leadership, to contact the PI, prior to and after his leaving the institution, with no response. Sincere efforts were made to obtain the data for reporting, but the data is unavailable.
Participant milestones
| Measure |
Treatment Arm 1
Bilateral TAP block consisting of 40cc. 0.125% bupivicaine + 0.5cc. dexamethasone (2mg.) per side.
Dexamethasone: 40 cc. 0.125% bupivicaine + 0.5cc. dexamethasone (2mg.) per side.
|
Treatment Arm 2
Bilateral TAP block of 40cc. of 0.125% bupivicaine + 0.5cc. sterile saline per side
TAP block: Bilateral TAP block of 40cc. of 0.125% bupivicaine + 0.5cc. sterile saline per side
|
|---|---|---|
|
Overall Study
STARTED
|
0
|
0
|
|
Overall Study
COMPLETED
|
0
|
0
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Evaluation of Addition of Dexamethasone to Transversus Abdominis Plane (TAP) Peripheral Nerve Block
Baseline characteristics by cohort
Baseline data not reported
PRIMARY outcome
Timeframe: 24 hours post-opPopulation: No data are available for this study, due to the fact that the PI has left the institution. Multiple efforts were made, by Research and senior leadership, to contact the PI, prior to and after his leaving the institution, with no response. Sincere efforts were made to obtain the data for reporting, but the data is unavailable.
Documenting the time required by patients to the first request of additional analgesia.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 24 hours post-opPopulation: No data are available for this study, due to the fact that the PI and study staff have left the institution. Multiple efforts were made, by Research and senior leadership, to contact the PI, prior to and after his leaving the institution, with no response. Sincere efforts were made to obtain the data for reporting, but the data is unavailable.
Outcome measures
Outcome data not reported
Adverse Events
Treatment Arm 1
Treatment Arm 2
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Meghan Cashman, IRB Manager
Steward St. Elizabeth's Medical Center
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place